Vertex Pharmaceuticals
VRTX
$455.34
Share price
2.77%
Change (1 day)
40.70%
Change (1 year)
Categories
Vertex Pharmaceuticals (VRTX) - Total assets
Total assets on the balance sheet as of March 2024 : $23.91 B
According to Vertex Pharmaceuticals's latest financial reports the company's total assets are $23.91 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Vertex Pharmaceuticals - Total assets on balance sheet (from 2001 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $22.73 B | 25.23% |
| 2022-12-31 | $18.15 B | 35.13% |
| 2021-12-31 | $13.43 B | 14.3% |
| 2020-12-31 | $11.75 B | 41.27% |
| 2019-12-31 | $8.31 B | 33.18% |
| 2018-12-31 | $6.24 B | 76.14% |
| 2017-12-31 | $3.54 B | 22.41% |
| 2016-12-31 | $2.89 B | 15.94% |
| 2015-12-31 | $2.49 B | 7.02% |
| 2014-12-31 | $2.33 B | 0.67% |
| 2013-12-31 | $2.31 B | -15.96% |
| 2012-12-31 | $2.75 B | 25.18% |
| 2011-12-31 | $2.20 B | 27.75% |
| 2010-12-31 | $1.72 B | -11.76% |
| 2009-12-31 | $1.95 B | 99.44% |
| 2008-12-31 | $0.98 B | 63.01% |
| 2007-12-31 | $0.60 B | -34.73% |
| 2006-12-31 | $0.92 B | 67.87% |
| 2005-12-31 | $0.54 B | 0.65% |
| 2004-12-31 | $0.54 B | -24.7% |
| 2003-12-31 | $0.72 B | -11.19% |
| 2002-12-31 | $0.81 B | -11.83% |
| 2001-12-31 | $0.92 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $171.96 B | 619.00% | 🇺🇸 USA |
 AbbVie ABBV | $148.87 B | 522.45% | 🇺🇸 USA |
 Gilead Sciences GILD | $56.29 B | 135.36% | 🇺🇸 USA |
 Merck MRK | $105.84 B | 342.56% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $99.03 B | 314.05% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | $0.41 B | -98.27% | 🇺🇸 USA |